F. M. Leweke

Electroconvulsive therapy enhances endocannabinoids in the cerebrospinal fluid of patients with major depression: a preliminary prospective study

A. Sartorius, M. Thiel, B. Lutz, 2017, European Archives of Psychiatry and Clinical Neuroscience.

Cannabis use and psychosis: a review of reviews

A. Hasan, W. Hall, F. Leweke, 2019, European Archives of Psychiatry and Clinical Neuroscience.

Increased ventral striatal CB1 receptor binding is related to negative symptoms in drug-free patients with schizophrenia

Koen Van Laere, Guy Bormans, Marc De Hert, 2013, NeuroImage.

Cannabinoid exposure in pubertal rats increases spontaneous ethanol consumption and NMDA receptor associated protein levels.

R. Spanagel, M. Klugmann, F. Leweke, 2011, The international journal of neuropsychopharmacology.

Oleoylethanolamide and human neural responses to food stimuli in obesity.

A. Meyer-Lindenberg, H. Tost, F. Leweke, 2014, JAMA psychiatry.

The endocannabinoid system as a target for modelling psychosis

F. Leweke, D. Koethe, C. Hoyer, 2009, Psychopharmacology.

Different pharmaceutical preparations of Δ9‐tetrahydrocannabinol differentially affect its behavioral effects in rats

H. Endepols, R. Graf, F. Pahlisch, 2019, Addiction biology.

Chronic pubertal cannabinoid treatment as a behavioural model for aspects of schizophrenia: effects of the atypical antipsychotic quetiapine.

F. Leweke, Miriam Schneider, F. M. Leweke, 2011, The international journal of neuropsychopharmacology.